Rhythm Pharmaceuticals, Inc. · NASDAQ:RYTM
Perceptive Advisors LLC reported a 5.10% stake in Rhythm Pharmaceuticals, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Perceptive Advisors LLC reported a 5.10% stake in Rhythm Pharmaceuticals, Inc., 3,519,626 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 5.10%
- Shares
- 3,519,626
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Perceptive Advisors LLC | 5.10% | 3,519,626 |
| Joseph Edelman | 5.10% | 3,519,626 |
| Perceptive Life Sciences Master Fund, Ltd. | 4.10% | 2,790,461 |
| Perceptive Capital Solutions Holdings LP | 1.10% | 729,165 |
Source
Related
- Rhythm Pharmaceuticals, Inc.
- Perceptive Advisors LLC
- Rhythm Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Perceptive Advisors LLC · May 15, 2025
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Meeker David P · Sep 14, 2026
- Form 4 · Smith Hunter C · Sep 1, 2026
- Form 4 · Shulman Joseph · Aug 17, 2026
- Form 4 · Garfield Alastair · Aug 17, 2026